• Abzug, M.J., 2014. The enteroviruses:problems in need of treatments. J. Infect. 68 Suppl 1, S108-114.

  • Benn, J.,Schneider, R.J., 1994. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc. Natl. Acad. Sci. U. S. A. 91, 10350-10354.

  • Bian, L., Wang, Y., Liu, Q., Xia, J.,Long, J.E., 2015. Prediction of signaling pathways involved in enterovirus 71 infection by algorithm analysis based on miRNA profiles and their target genes. Arch. Virol. 160, 173-182.

  • Bogoyevitch, M.A.,Kobe, B., 2006. Uses for JNK:the many and varied substrates of the c-Jun N-terminal kinases. Microbiol. Mol. Biol. Rev. 70, 1061-1095.

  • Cáceres, C.J., Hu, Y., Cárdenas-García, S., Wu, X., Tan, H., Carnaccini, S., Gay, L.C., Geiger, G., Ma, C., Zhang, Q.Y., Rajao, D., Perez, D.R.,Wang, J., 2021. Rational design of a deuterium-containing M2-S31N channel blocker UAWJ280 with in vivo antiviral efficacy against both oseltamivir sensitive and -resistant influenza A viruses. Emerg. Microbes. Infect. 10, 1832-1848.

  • Chang, L.Y., Tsao, K.C., Hsia, S.H., Shih, S.R., Huang, C.G., Chan, W.K., Hsu, K.H., Fang, T.Y., Huang, Y.C.,Lin, T.Y., 2004. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA. 291, 222-227.

  • Chong, P., Liu, C.C., Chow, Y.H., Chou, A.H.,Klein, M., 2015. Review of enterovirus 71 vaccines. Clin. Infect. Dis. 60, 797-803.

  • Dai, W., Xie, S., Chen, C.,Choi, B.H., 2021. Ras sumoylation in cell signaling and transformation. Semin. Cancer Biol. 76, 301-309.

  • Flory, E., Weber, C.K., Chen, P., Hoffmeyer, A., Jassoy, C.,Rapp, U.R., 1998. Plasma membrane-targeted Raf kinase activates NF-kappaB and human immunodeficiency virus type 1 replication in T lymphocytes. J. Virol. 72, 2788-2794.

  • Ghasemnejad-Berenji, M.,Pashapour, S., 2021. SARS-CoV-2 and the Possible Role of Raf/MEK/ERK Pathway in Viral Survival:Is This a Potential Therapeutic Strategy for COVID-19? Pharmacology, 106, 119-122.

  • Han, Y., Chen, Z., Zheng, K., Li, X., Kong, J., Duan, X., Xiao, X., Guo, B., Luan, R.,Long, L., 2020. Epidemiology of Hand, Foot, and Mouth Disease Before and After the Introduction of Enterovirus 71 Vaccines in Chengdu, China, 2009-2018. Pediatr Infect Dis J, 39, 969-978.

  • Huber, M., Watson, K.A., Selinka, H.C., Carthy, C.M., Klingel, K., Mcmanus, B.M.,Kandolf, R., 1999. Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication. J. Virol. 73, 3587-3594.

  • Ji, X.,Li, Z., 2020. Medicinal chemistry strategies toward host targeting antiviral agents. Med. Res. Rev. 40, 1519-1557.

  • Khojasteh Poor, F., Keivan, M., Ramazii, M., Ghaedrahmati, F., Anbiyaiee, A., Panahandeh, S., Khoshnam, S.E.,Farzaneh, M., 2021. Mini review:The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer. Breast Dis. 40, 51-62.

  • Leong, S.Y., Ong, B.K.,Chu, J.J., 2015. The role of Misshapen NCK-related kinase (MINK), a novel Ste20 family kinase, in the IRES-mediated protein translation of human enterovirus 71. PLoS Pathog. 11, e1004686.

  • Ludwig, S., 2011. Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections. Biol. Chem. 392, 837-847.

  • Ludwig, S., Planz, O., Pleschka, S.,Wolff, T., 2003. Influenza-virus-induced signaling cascades:targets for antiviral therapy? Trends Mol. Med. 9, 46-52.

  • Ludwig, S., Wolff, T., Ehrhardt, C., Wurzer, W.J., Reinhardt, J., Planz, O.,Pleschka, S., 2004. MEK inhibition impairs influenza B virus propagation without emergence of resistant variants. FEBS Lett. 561, 37-43.

  • Nagata, K., Kawaguchi, A.,Naito, T., 2008. Host factors for replication and transcription of the influenza virus genome. Rev. Med. Virol. 18, 247-260.

  • Pei, Z., Wang, H., Zhao, Z., Chen, X., Huan, C.,Zhang, W., 2022. Chemokine PF4 Inhibits EV71 and CA16 Infections at the Entry Stage. J. Virol. 96, e0043522.

  • Pleschka, S., Wolff, T., Ehrhardt, C., Hobom, G., Planz, O., Rapp, U.R.,Ludwig, S., 2001. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat. Cell Biol. 3, 301-305.

  • Schmidt, N.J., Lennette, E.H.,Ho, H.H., 1974. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis, 129, 304-309.

  • Tung, W.H., Hsieh, H.L.,Yang, C.M., 2010. Enterovirus 71 induces COX-2 expression via MAPKs, NF-kappaB, and AP-1 in SK-N-SH cells:Role of PGE(2) in viral replication. Cell Signal. 22, 234-246.

  • Wang, J., Hu, Y.,Zheng, M., 2022. Enterovirus A71 antivirals:Past, present, and future. Acta Pharm. Sin. B, 12, 1542-1566.

  • Wen, T., Xu, W., Liang, L., Li, J., Ding, X., Chen, X., Hu, J., Lv, A.,Li, X., 2015. Clinical Efficacy of Andrographolide Sulfonate in the Treatment of Severe Hand, Foot, and Mouth Disease (HFMD) is Dependent upon Inhibition of Neutrophil Activation. Phytother. Res. 29, 1161-1167.

  • Xu, N., Yang, J., Zheng, B., Zhang, Y., Cao, Y., Huan, C., Wang, S., Chang, J.,Zhang, W., 2020. The Pyrimidine Analog FNC Potently Inhibits the Replication of Multiple Enteroviruses. J. Virol. 94.

  • Yang, Q., Zhang, Q., Zhang, X., You, L., Wang, W., Liu, W., Han, Y., Ma, C., Xu, W., Chen, J., Yang, H., Wan, P., Zhou, Y., Liu, Y., Wu, K., Yang, Z.,Wu, J., 2019. HoxA10 Facilitates SHP-1-Catalyzed Dephosphorylation of p38 MAPK/STAT3 To Repress Hepatitis B Virus Replication by a Feedback Regulatory Mechanism. J. Virol. 93.

  • Yao, Z., Gao, Y., Su, W., Yaeger, R., Tao, J., Na, N., Zhang, Y., Zhang, C., Rymar, A., Tao, A., Timaul, N.M., Mcgriskin, R., Outmezguine, N.A., Zhao, H., Chang, Q., Qeriqi, B., Barbacid, M., De Stanchina, E., Hyman, D.M., Bollag, G.,Rosen, N., 2019. RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling. Nat. Med. 25, 284-291.

  • Yee, P.T.I.,Laa Poh, C., 2017. Impact of genetic changes, pathogenicity and antigenicity on Enterovirus- A71 vaccine development. Virology, 506, 121-129.

  • Yi, E.J., Shin, Y.J., Kim, J.H., Kim, T.G.,Chang, S.Y., 2017. Enterovirus 71 infection and vaccines. Clin. Exp. Vaccine Res. 6, 4-14.

  • Yin, R., Liu, X., Bi, Y., Xie, G., Zhang, P., Meng, X., Ai, L., Xu, R., Sun, Y., Stoeger, T.,Ding, Z., 2015. Expression of Raf kinase inhibitor protein is downregulated in response to Newcastle disease virus infection to promote viral replication. J. Gen. Virol. 96, 2579-2586.

  • Yip, C.C., Lau, S.K., Woo, P.C.,Yuen, K.Y., 2013. Human enterovirus 71 epidemics:what's next? Emerg. Health Threats J. 6, 19780.

  • Zhang, L., Wei, M., Jin, P., Li, J.,Zhu, F., 2021. An evaluation of a test-negative design for EV-71 vaccine from a randomized controlled trial. Hum. Vaccin. Immunother. 17, 2101-2106.